Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sheridan Marie Wilson
Observed names:
S Wilson,
Sheridan Wilson,
Wilson Sheridan
Institution:
Health New Zealand
Observed institutions:
BC Cancer Agency,
University of British Columbia,
Auckland City Hospital,
Auckland District Health Board,
Health New Zealand
ORCID:
0009-0008-5446-7067
Observed ORCID:
0009-0008-5446-7067
OpenAlex ID:
A5074587105
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2017
·
Eric Y. Zhao
, Yaoqing Shen
, et al.
·
Clinical Cancer Research
·
201
Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
2014
·
Wilson Sheridan
, Tyldesley Scott
, et al.
·
Breast Cancer Research and Treatment
·
94
A double-blind placebo controlled randomized phase III trial of fulvestrant and ipatasertib as treatment for advanced HER2-negative and estrogen receptor positive (ER+) breast cancer following progression on first line CDK 4/6 inhibitor and aromatase inhibitor: The CCTG/BCT MA.40/FINER study (NCT04650581).
2025
·
Stephen K. L. Chia
, Andrew David Redfern
, et al.
·
Journal of Clinical Oncology
·
25
PDF
Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward
2013
·
Sheridan Wilson
, Stephen K. Chia
·
American Society of Clinical Oncology Educational Book
·
16
IGF-1R inhibition: right direction, wrong pathway?
2013
·
Sheridan Wilson
, Stephen K Chia
·
The Lancet Oncology
·
12
Pacific Peoples' Experiences of Cancer and Its Treatment in Aotearoa New Zealand Through Talanoa: A Qualitative Study of Samoan and Tongan Participants
2025
·
Olivia M. Perelini
, Vili H. Nosa
, et al.
·
JCO Global Oncology
·
7
Pseudomyxoma peritonei metastatic to the bone: case report and review of systemic management.
2014
·
Renata D'Alpino Peixoto
, Sheridan Wilson
, et al.
·
PubMed
·
7
Proton pump inhibition to prevent delayed chemotherapy-induced nausea and vomiting in patients receiving adjuvant or neoadjuvant breast cancer chemotherapy: a phase II, randomised double-blind crossover trial (PantoCIN)
2025
·
Navin Wewala
, Yujin Kim
, et al.
·
Supportive Care in Cancer
·
5
Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer
2015
·
Sheridan Wilson
, Caroline Speers
, et al.
·
Clinical Breast Cancer
·
4
Survival Outcomes and Care Equity among Patients with Advanced Breast Cancer in Auckland, New Zealand
2022
·
Edmond Ang
, Dug Yeo Han
, et al.
·
Journal of Cancer Epidemiology
·
2
PDF
New agents in locally advanced breast cancer
2013
·
Sheridan Wilson
, Stephen Chia
·
Current Opinion in Supportive and Palliative Care
·
1
Supplementary Information from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023
·
Eric Y. Zhao
, Yaoqing Shen
, et al.
Supplementary Table 5 from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023
·
Eric Y. Zhao
, Yaoqing Shen
, et al.
Data from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023
·
Eric Y. Zhao
, Yaoqing Shen
, et al.
Data from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
2023
·
Eric Y. Zhao
, Yaoqing Shen
, et al.
Six cycles of adjuvant anthracycline-taxane-based chemotherapy compared with eight cycles for women with breast cancer.
2019
·
Michael Lee
, Sheridan Wilson
, et al.
·
Journal of Clinical Oncology
Abstract 2046: Analysis of over-expressed chromosomal regions identifies YBX1 oncogene amplification in basal-like breast tumors
2015
·
Abbey Jebb
, Sandra Fitzgerald
, et al.
·
Cancer Research
Do care pathways help us choose wisely in the setting of neoadjuvant therapy for breast cancer? Results of a pre-post analysis.
2015
·
Rachel Adilman
, Dimas Yusuf
, et al.
·
Journal of Clinical Oncology
Outcomes of 3-weekly doxorubicin and cyclophosphamide followed by paclitaxel (AC/T) in a randomized trial (RCT) compared to a case-control matched British Columbia (BC) breast cancer population.
2014
·
Sheridan Marie Wilson
, Yvonne Zheng
, et al.
·
Journal of Clinical Oncology
Long-term population-based outcomes of adjuvant trastuzumab in HER2-positive early breast cancer: The British Columbia experience.
2014
·
Stephen K. L. Chia
, Caroline Speers
, et al.
·
Journal of Clinical Oncology
When is downstream pathway inhibition important?
2014
·
Sheridan Wilson
, Stephen K Chia
·
The Lancet Oncology
Abstract P6-06-04: Breast cancer in young women: Have the prognostic and predictive implications of breast cancer subtypes changed over time?
2013
·
S Wilson
, S Tyldesley
, et al.
·
Cancer Research
Show more works
View as search
Works count:
22
Citation count:
374
H-index:
7
I10-index:
5
Year
Topic
Type